from Atacand)Jump atacand substitutes navigation, searchCandesartanSystematic (IUPAC) name3-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-3H-benzo[d]imidazole-4-carboxylic acidIdentifiersCAS number 139481-59-7ATC code C09CA06PubChem 2541DrugBank APRD00420Chemical dataFormula C24H20N6O3Mol. mass.

patients with atacand substitutes heart failure: the CHARM-Overall programme.". Lancet 362 (9386): 759–66. PMID 13678868.[edit] External linksAtacand web site or Atacand US, run by AstraZenecaCandesartan[hide]v • d • eAgents acting on the renin-angiotensin system (C09)ACE inhibitors Benazepril • Captopril • Enalapril • Fosinopril • Lisinopril • Perindopril • Quinapril • Ramipril • Spirapril • TrandolaprilAngiotensin II receptor antagonist used mainly for the treatment atacand substitutes hypertension. The prodrug atacand substitutes cilexetil is metabolised completely atacand substitutes esterases in the early atacand substitutes demonstrated the morbidity and mortality reduction benefits of candesartan therapy in congestive heart atacand substitutes Thus, while ACE inhibitors are still considered first-line therapy in congestive heart failure.[1] atacand substitutes while ACE inhibitors are still considered first-line therapy in heart failure, candesartan can be used in combination with an ACE to achieve improved mortality and morbidity in patients atacand substitutes of ACE.

cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress.